Invention Grant
- Patent Title: Anti-CD40 antibodies
- Patent Title (中): 抗CD40抗体
-
Application No.: US14165400Application Date: 2014-01-27
-
Publication No.: US09567401B2Publication Date: 2017-02-14
- Inventor: Jacques F. Banchereau , Gerard Zurawski , Sandra Zurawski , SangKon Oh
- Applicant: Baylor Research Institute
- Applicant Address: US TX Dallas
- Assignee: BAYLOR RESEARCH INSTITUTE
- Current Assignee: BAYLOR RESEARCH INSTITUTE
- Current Assignee Address: US TX Dallas
- Agency: Norton Rose Fulbright US LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; C07K14/005 ; A61K39/00
Abstract:
The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccines and antigen delivery vectors, to delivery antigens to antigen presenting cells. In one embodiment, the vector is an anti-CD40 antibody, or fragments thereof, and one or more antigenic peptides linked to the anti-CD40 antibody or fragments thereof, including humanized antibodies.
Public/Granted literature
- US20140234344A1 ANTI-CD40 ANTIBODIES AND USES THEREOF Public/Granted day:2014-08-21
Information query
